RBMY, a novel inhibitor of glycogen synthase kinase 3β, increases tumor stemness and predicts poor prognosis of hepatocellular carcinoma

Hepatology

Volumn 62, Issue 5, 2015, Pages 1480-1496

  Chua, Huey Huey ^a   Tsuei, Daw Jen ^a   Lee, Po Huang ^a   Jeng, Yung Ming ^a   Lu, Jean ^b   Wu, Jia Feng ^a   Su, De Shiuan ^a   Chen, Ya Hui ^c   Chien, Chin Sung ^c   Kao, Pei Chi ^c   Lee, Chien Nan ^a   Hu, Rey Heng ^a   Ni, Yen Hsuan ^a   Chang, Mei Hwei ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA; MINICHROMOSOME MAINTENANCE PROTEIN 1; ONCOFETAL ANTIGEN; RBMY PROTEIN; SERINE; THREONINE; UNCLASSIFIED DRUG; WNT3A PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; NUCLEAR EXPORT SIGNAL; NUCLEAR PROTEIN; RBMY1A1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CANCER TISSUE; CELL CYCLE PROGRESSION; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CELL RENEWAL; CHROMOSOME STRUCTURE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; FETUS; FETUS LIVER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER DEVELOPMENT; MALE; MOUSE; NONHUMAN; ONCOGENE; ONTOGENY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; RNA BINDING MOTIF ON THE Y CHROMOSOME; SURVIVAL RATE; TUMOR XENOGRAFT; WNT SIGNALING PATHWAY; Y CHROMOSOME; ANIMAL; ANTAGONISTS AND INHIBITORS; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MORTALITY; NUCLEAR EXPORT SIGNAL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROGNOSIS; PROTEIN STABILITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INFANT; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR EXPORT SIGNALS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROGNOSIS; PROTEIN STABILITY; RATS; RNA-BINDING PROTEINS; WNT3A PROTEIN;

EID: 84945439843     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27996     Document Type: Article

References (36)

1. Forman D, Ferlay J. The global and regional burden of cancer. In: Stewart BW, Wild CP, Bray F, Forman D, Ohgaki H, Straif K, Ullrich A, eds. World Cancer Report 2014. Lyon, France: International Agency for Research on Cancer of World Health Organization; 2014:26-69.
2. Chang MH, You SL, Chen CJ, Liu CJ, Lee CM, Lin SM, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009;101:1348-1355.
3. Kushnir MM, Blamires T, Rockwood AL, Roberts WL, Yue B, Erdogan E, et al. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem 2010;56:1138-1147.
4. Williams DA, Xu H, Cancelas JA. Children are not little adults: just ask their hematopoietic stem cells. J Clin Invest 2006;116:2593-2596.
5. Chiba T, Zheng YW, Kita K, Yokosuka O, Saisho H, Onodera M, et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 2007;133:937-950.
6. Yamashita T, Wang XW. Cancer stem cells in the development of liver cancer. J Clin Invest 2013;123:1911-1918.
7. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 1996;272:1023-1026.
8. Li VS, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, et al. Wnt signaling through inhibition of beta-catenin degradation in an intact Axin1 complex. Cell 2012;149:1245-1256.
9. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-1512.
10. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-426.
11. Tsuei DJ, Lee PH, Peng HY, Lu HL, Su DS, Jeng YM, et al. Male germ cell-specific RNA binding protein RBMY: a new oncogene explaining male predominance in liver cancer. PLoS One 2011;6:e26948.
12. Tsuei DJ, Hsu HC, Lee PH, Jeng YM, Pu YS, Chen CN, et al. RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts. Oncogene 2004;23:5815-5822.
13. Bellott DW, Hughes JF, Skaletsky H, Brown LG, Pyntikova T, Cho TJ, et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 2014;508:494-499.
14. Chai NN, Salido EC, Yen PH. Multiple functional copies of the RBM gene family, a spermatogenesis candidate on the human Y chromosome. Genomics 1997;45:355-361.
15. Elliott DJ, Ma K, Kerr SM, Thakrar R, Speed R, Chandley AC, et al. An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. Hum Mol Genet 1996;5:869-874.
16. Prosser J, Inglis JD, Condie A, Ma K, Kerr S, Thakrar R, et al. Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. Mamm Genome 1996;7:835-842.
17. Elliott DJ, Millar MR, Oghene K, Ross A, Kiesewetter F, Pryor J, et al. Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci USA 1997;94:3848-3853.
18. Heinrich B, Zhang Z, Raitskin O, Hiller M, Benderska N, Hartmann AM, et al. Heterogeneous nuclear ribonucleoprotein G regulates splice site selection by binding to CC(A/C)-rich regions in pre-mRNA. J Biol Chem 2009;284:14303-14315.
19. Dreumont N, Bourgeois CF, Lejeune F, Liu Y, Ehrmann IE, Elliott DJ, et al. Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-β. J Cell Sci 2010;123:40-50.
20. Venables JP, Elliott DJ, Makarova OV, Makarov EM, Cooke HJ, Eperon IC. RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing. Hum Mol Genet 2000;9:685-694.
21. Yu CH, Chen HL, Chen WT, Ni YH, Lin YL, Chang MH. Portal hemodynamic changes after hepatocyte transplantation in acute hepatic failure. J Biomed Sci 2004;11:756-763.
22. Kutay U, Guttinger S. Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol 2005;15:121-124.
23. Turner R, Lozoya O, Wang Y, Cardinale V, Gaudio E, Alpini G, et al. Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011;53:1035-1045.
24. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005;5:899-904.
25. van Zijl F, Mikulits W. Hepatospheres: Three dimensional cell cultures resemble physiological conditions of the liver. World J Hepatol 2010;2:1-7.
26. Frame S, Cohen P, Biondi RM. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 2001;7:1321-1327.
27. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012;149:1192-1205.
28. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006;12:410-416.
29. Inada M, Benten D, Cheng K, Joseph B, Berishvili E, Badve S, et al. Stage-specific regulation of adhesion molecule expression segregates epithelial stem/progenitor cells in fetal and adult human livers. Hepatol Int 2008;2:50-62.
30. Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med 2013;368:2266-2276.
31. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002;298:1912-1934.
32. Zulehner G, Mikula M, Schneller D, van Zijl F, Huber H, Sieghart W, et al. Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. Am J Pathol 2010;176:472-481.
33. Mokkapati S, Niopek K, Huang L, Cunniff KJ, Ruteshouser EC, deCaestecker M, et al. Beta-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma. Cancer Res 2014;74:4515-4525.
34. Liu G, Jiang S, Wang C, Jiang W, Liu Z, Liu C, et al. Zinc finger transcription factor 191, directly binding to beta-catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Hepatology 2012;55:1830-1839.
35. Feng H, Cheng AS, Tsang DP, Li MS, Go MY, Cheung YS, et al. Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives beta-catenin/T cell factor-dependent hepatocarcinogenesis. J Clin Invest 2011;121:3159-3175.
36. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell 2005;19:159-170.